Enstilar

Drug Overview

Enstilar is a highly advanced, dual-action medication utilized extensively in the field of Dermatology. It is a specialized topical foam that combines two powerful ingredients to treat stubborn, scaly skin plaques. By delivering both an anti-inflammatory and a skin-normalizing agent in a rapidly absorbing foam, it functions as a highly effective Targeted Therapy to clear skin lesions faster than using either medication alone.

Here are the essential details about this medication:

• Generic Name: Calcipotriol (also known as Calcipotriene in the US) + Betamethasone Dipropionate
• US Brand Names: Enstilar
• Drug Category: Dermatology
• Drug Class: Vitamin D3 Analogue / Topical Corticosteroid
• Route of Administration: Topical (applied directly to the skin as an aerosol foam)
• FDA Approval Status: FDA-approved (for patients 12 years of age and older)

What Is It and How Does It Work? (Mechanism of Action)

Enstilar combines a synthetic form of Vitamin D (calcipotriol) with a strong steroid (betamethasone). In plaque psoriasis, the immune system is hyperactive, causing skin cells (keratinocytes) to multiply far too quickly and pile up into thick, red, scaly patches. Enstilar uses two distinct molecular pathways to combat this.

1. Calcipotriol (The Cell Normalizer): This ingredient acts as a precise Targeted Therapy. Once it enters the skin cell, it binds to the Vitamin D Receptor (VDR). This complex then travels into the cell’s nucleus and pairs with the Retinoid X Receptor (RXR). Together, they bind to the DNA to switch off the genes that cause rapid cell division (hyperproliferation) and switch on the genes that tell the skin cells to mature normally (differentiation).
2. Betamethasone (The Inflammatory Blocker): This strong corticosteroid enters the skin cell and binds to the glucocorticoid receptor. It travels to the DNA and dramatically increases the production of an anti-inflammatory protein called lipocortin-1. Lipocortin-1 blocks the enzyme phospholipase A2. This cuts off the body’s supply of arachidonic acid, completely stopping the production of prostaglandins and leukotrienes—the chemicals that make the psoriasis plaques red, swollen, and itchy.
3. The Synergistic Effect: The combination of these two drugs is incredibly powerful. The steroid quickly reduces the redness and itching, while the Vitamin D analogue stops the excessive scaling. Furthermore, the steroid helps reduce the skin irritation that calcipotriol can sometimes cause when used by itself.

FDA-Approved Clinical Indications

Primary Indication

• Plaque Psoriasis: Enstilar is specifically approved for the topical treatment of plaque psoriasis in patients 12 years of age and older.

Other Approved Uses

• Currently, Enstilar foam is FDA-approved solely for plaque psoriasis. * Off-Label Uses: Dermatologists sometimes utilize it to treat severe scalp psoriasis, as the foam formulation easily penetrates through hair to reach the scalp skin.

Dosage and Administration Protocols

Enstilar is an aerosol foam that should be applied directly to the psoriasis plaques. Because it contains a strong steroid and a Vitamin D analogue, strict limits on dosage and duration must be followed to prevent it from affecting the body’s internal hormone or calcium levels.

Dose Adjustments and Special Populations:

• Body Surface Area Limits: Do not apply Enstilar to more than 30% of your total body surface area to prevent excessive drug absorption into the bloodstream.
• Renal and Hepatic Insufficiency: Patients with severe kidney or liver disease should use this medication with caution. Because the kidneys regulate the body’s calcium, absorbing too much calcipotriol can cause dangerously high blood calcium levels in these patients.
• Pediatric Patients: It is approved for adolescents 12 to 17 years old, but safety is not established for younger children. Children absorb more medication through their skin, making them more susceptible to side effects.

Clinical Efficacy and Research Results

Enstilar foam has proven to be one of the most effective topical treatments for psoriasis available today. Its unique supersaturated foam delivery system allows the active ingredients to penetrate the skin much better than traditional ointments. Recent clinical reviews (2020–2026) highlight the following:

• Treatment Success: In major clinical trials, over 50% to 53% of patients using Enstilar achieved “clear” or “almost clear” skin (measured by the Physician Global Assessment) within just 4 weeks of once-daily use.
• PASI 75 Response: Over half of the patients achieve a PASI 75 response (a 75% reduction in their Psoriasis Area and Severity Index score) by the end of the 4-week treatment block.
• Rapid Itch Relief: Patients typically report a significant and measurable reduction in severe itching (pruritus) within the first 3 to 5 days of therapy.

Safety Profile and Side Effects

Note: Enstilar does not carry a Black Box Warning, but it is highly flammable due to the propellants in the foam. Patients must avoid fire, flame, and smoking during and immediately following application.

Common Side Effects (Occurring in >10% of patients)

• Application site reactions (mild irritation, burning, or stinging)
• Folliculitis (small red bumps or infections in the hair follicles)
• Worsening or “rebound” of psoriasis if the medication is stopped abruptly after long-term use
• Changes in skin color (hyperpigmentation or hypopigmentation)

Serious Adverse Events

• Hypercalcemia: Absorbing too much calcipotriol can cause dangerously high calcium levels in the blood or urine. Symptoms include excessive thirst, frequent urination, muscle weakness, and confusion.
• HPA Axis Suppression: Because it contains a strong steroid, overuse can suppress the body’s adrenal glands, temporarily stopping them from making natural stress hormones.
• Skin Atrophy: Long-term, continuous use can permanently thin the skin, causing stretch marks and easy bruising.

Management Strategies

• To prevent skin thinning and adrenal suppression, use Enstilar only for the prescribed 4 weeks. If the psoriasis returns, your doctor may recommend taking a break before starting another short course.
• If you experience extreme thirst and weakness, stop using the medication and contact your doctor for a simple blood test to check your calcium levels.

Connection to Stem Cell and Regenerative Medicine

While Enstilar is a traditional pharmaceutical foam, its mechanism is highly relevant to modern regenerative dermatology research (2024-2026). In severe plaque psoriasis, the skin’s epidermal stem cells are trapped in a constant cycle of panic and hyperproliferation due to the intense autoimmune inflammation.

By applying this dual-action Targeted Therapy, the betamethasone quickly shuts down the toxic inflammatory storm, while the calcipotriol directly commands the confused stem cells to mature properly instead of just multiplying. Clinical researchers believe that using highly effective delivery systems like Enstilar provides a fast “reset” for the skin. By rapidly calming the microenvironment, the native stem cells in the hair follicles and basal layer can safely regenerate a healthy, normal skin barrier without the prolonged tissue damage caused by months of uncontrolled inflammation.

Patient Management and Practical Recommendations

Pre-Treatment Tests

• Visual Assessment: A healthcare provider must confirm the plaques are psoriasis. Applying this medication to a fungal or viral skin infection will make the infection significantly worse.
• Calcium Check (If applicable): If a patient has a history of kidney issues or calcium metabolism disorders, a baseline blood calcium test should be performed.

Precautions During Treatment

• Flammability Warning: The foam contains highly flammable propellants. Do not smoke, use a hair dryer, or stand near an open flame (like a stove or candle) while applying the foam and until it has completely dried.
• Sun Sensitivity: Calcipotriol makes your skin more sensitive to the sun. Avoid artificial tanning beds and use sunscreen/protective clothing when outdoors. Do not apply Enstilar right before undergoing clinical UV phototherapy.
• Avoid Sensitive Areas: Do not apply Enstilar to your face, groin, or armpits unless strictly directed by a dermatologist. The skin there is thin and highly prone to steroid damage.

Do’s and Don’ts

• DO shake the can well for a few seconds before every use.
• DO wash your hands thoroughly with soap and water immediately after rubbing the foam in, so you don’t accidentally transfer it to your eyes or face.
• DO apply a regular, unmedicated moisturizer throughout the day to keep the plaques hydrated, but wait at least 30 minutes after using Enstilar.
• DON’T cover the treated plaques with tight, non-breathable bandages or plastic wrap (occlusion), as this forces too much of the strong steroid into your bloodstream.
• DON’T wash the treated area immediately after applying. Leave the foam on the skin (usually overnight or all day) to allow the medication to fully absorb.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical diagnosis, treatment, or clinical guidance. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment plan. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.